Nektar Therapeutics · NASDAQ:NKTR
Zalevsky Jonathan sold 5,538 Nektar Therapeutics shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 17, 2026
On Jun 15, 2026, Zalevsky Jonathan (Chief R&D Officer) sold 5,538 Nektar Therapeutics shares at US$60.71 for US$336K under a trading plan, leaving 15,437 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 5,538 shares
- Price
- US$60.71
- Value
- US$336K
- Holding after
- 15,437 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief R&D Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Sale | 5,538 | US$60.71 | 15,437 | Direct |
Source
Related
- Nektar Therapeutics
- Zalevsky Jonathan
- Nektar Therapeutics shareholders
- Form 4 · Zalevsky Jonathan · Aug 20, 2026
- Form 4 · Zalevsky Jonathan · Jul 2, 2026
- Form 4 · Zalevsky Jonathan · May 21, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026